Zobrazeno 1 - 9
of 9
pro vyhledávání: '"John B, Korman"'
Publikováno v:
JAAD Case Reports, Vol 6, Iss 10, Pp 1053-1055 (2020)
Externí odkaz:
https://doaj.org/article/b0d85ede1fe34e0b80df0458a13a9131
Publikováno v:
Dermatology online journal. 25(5)
Cutaneous epithelioid angiosarcoma is a rare neoplasm of vascular endothelial cell origin that can mimic a cutaneous lymphoma, metastatic carcinoma, or Kaposi sarcoma. It is one of the most malignant cutaneous tumors and early diagnosis is essential,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::4d1d8a7c9705d87df9f5f60dbc22c6b8
https://pubmed.ncbi.nlm.nih.gov/31220903
https://pubmed.ncbi.nlm.nih.gov/31220903
Publikováno v:
Dermatologic Surgery. 39:1587-1591
Botulinum neurotoxin (BoNT) has diverse cosmetic and therapeutic applications, spanning multiple medical specialties. Recent lawsuits alleging complications from its clinical use have raised significant questions about medicolegal risk.To identify an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e6b7fe8dcce15e373bc2d0dc6793fb41
https://doi.org/10.1111/dsu.12188
https://doi.org/10.1111/dsu.12188
Autor:
Aliyah R. Sohani, John B. Korman, Long P. Le, Abner Louissaint, Robert P. Hasserjian, Lyn M. Duncan, Amir Aboutalebi, Stefan Kraft, Rosalynn M. Nazarian
Publikováno v:
Journal of Cutaneous Pathology. 40:996-1005
Background Aleukemic cutaneous myeloid sarcoma (CMS) represents an important yet rare entity denoting the presence of a cutaneous myeloid leukemic infiltrate without concurrent peripheral blood or bone marrow disease. The clinicopathologic diagnosis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ce24d97266773d61998282398d94ae76
https://doi.org/10.1111/cup.12231
https://doi.org/10.1111/cup.12231
Autor:
David E. Fisher, John B. Korman
Publikováno v:
WIREs Systems Biology and Medicine. 5:257-271
Melanoma is a common, often deadly malignancy, historically associated with limited treatment options for advanced disease. In recent years, systems-based research has resulted in significant clinical advancements. Strategic inhibition of mutated onc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::15df3651d7a9ae45aaf4427294cc3d3c
https://doi.org/10.1002/wsbm.1210
https://doi.org/10.1002/wsbm.1210
Autor:
Amir, Aboutalebi, John B, Korman, Aliyah R, Sohani, Robert P, Hasserjian, Abner, Louissaint, Long, Le, Stefan, Kraft, Lyn M, Duncan, Rosalynn M, Nazarian
Publikováno v:
Journal of cutaneous pathology. 40(12)
Aleukemic cutaneous myeloid sarcoma (CMS) represents an important yet rare entity denoting the presence of a cutaneous myeloid leukemic infiltrate without concurrent peripheral blood or bone marrow disease. The clinicopathologic diagnosis remains elu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::0ee7d739db0ffc8364c5c7e76c46ec10
https://pubmed.ncbi.nlm.nih.gov/24274424
https://pubmed.ncbi.nlm.nih.gov/24274424
Publikováno v:
Journal of the American Academy of Dermatology. 69:e314-e315
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::50e46a689768123bb7ffec9507dd320a
https://doi.org/10.1016/j.jaad.2013.08.020
https://doi.org/10.1016/j.jaad.2013.08.020
Autor:
James S. Norris, Yusuf A. Hannun, Lina M. Obeid, Xiang Liu, Youssef H. Zeidan, Russell W. Jenkins, John B. Korman
Publikováno v:
Current drug targets. 9(8)
Increasingly recognized as bioactive molecules, sphingolipids have been studied in a variety of disease models. The impact of sphingolipids on cancer research facilitated the entry of sphingolipid analogues and enzyme modulators into clinical trials.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bf392cd6d51662d7a27449b73a65f882
https://pubmed.ncbi.nlm.nih.gov/18691012
https://pubmed.ncbi.nlm.nih.gov/18691012
Publikováno v:
Archives of Dermatology. 146:918
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b147a08473c43e7f3583e8d237c614a5
https://doi.org/10.1001/archdermatol.2010.170
https://doi.org/10.1001/archdermatol.2010.170